Non ci sono recensioni
High-Normal Blood Pressure in Children and Adolescents
Pages 3-16
This book sheds new light on the management of patients with borderline cardiovascular risk factors in order to prevent their progression to end organ damage. The book stimulates discussion of this poorly understood condition and lays the groundwork for developing recommendations and guidelines.
While the diagnostic and therapeutic approach to full-blown diabetes, hypertension, dyslipidemia and obesity is well defined, there is still a lack of clear understanding and guidelines as far as patients with borderline conditions – especially when multiple – are concerned. Moreover, end-organ damage depends on several factors, including genetic factors, making it difficult to predict its extent. As such, the gradual transition from a healthy subject to one with functional hemodynamic changes, and then one with structurally asymptomatic changes and lastly to overt disease needs further investigation.
In order to address these knowledge gaps, the book covers a broad variety of topics, making it a valuable tool for identifying which asymptomatic subjects could profit from being appropriately screened and at what stage. Furthermore it offers insights into better treating these patients to prevent their progression to overt disease. The book appeals to cardiologists, primary care physicians and all those healthcare professional looking to optimize the management of these complex and often undiagnosed cases.
High-Normal Blood Pressure in Children and Adolescents
Pages 3-16
History of Prehypertension: Past and Present, a Saga of Misunderstanding and Neglect
Pages 17-26
Parental History of Hypertension as the Determinant of Cardiovascular Function
Pages 27-36
Prehypertension, the Risk of Hypertension and Events
Pages 37-55
Prehypertension and the Cardiometabolic Syndrome
Pages 57-66
Prehypertension: Definition and Epidemiology
Pages 67-77
Prehypertension, Statistics and Health Burden
Pages 79-98
Arterial Stiffness in Early Phases of Prehypertension
Pages 101-126
Central Blood Pressure and Prehypertension
Pages 127-136
Diurnal and Pulsatile Hemodynamics in Individuals with Prehypertension
Pages 137-147
Early Changes in Renal Vasculature in Prehypertension
Pages 149-157
Heart and Prehypertension
Pages 159-170
Hemodynamics of Prehypertension
Pages 171-182
Microvascular Structural Alterations and Tissue Perfusion in Hypertension/Diabetes
Pages 183-196
Obesity-Hypertension Physiopathology and Treatment: A Forty-Year Retrospect
Pages 197-229
Pre-chronic Kidney Disease (CKD)? Is It Time for a New Staging?
Pages 231-240
Prehypertension and Vascular-Renal Impairment
Pages 241-249
Subclinical Vascular Damage in Prehypertension
Pages 251-256
Systolic Hypertension in Youth
Pages 257-270
The Role of Perivascular Fat in Raising Blood Pressure in Obesity and Diabetes
Pages 271-288
Endothelial Dysfunction in Early Phases of Hypertension
Pages 291-306
Prehypertension and the Renin-Angiotensin-Aldosterone System
Pages 307-318
Tachycardia in Prehypertension
Pages 319-339
The Role of the Brain in Prehypertension
Pages 341-348
The Role of the Brain in Neurogenic Prehypertension
Pages 349-360
Blood Pressure and Atherosclerosis: Subclinical Arteriosclerosis as an Early Sign of Organ Damage
Pages 363-381
Blood Pressure Measurement, White-Coat and Masked Hypertension
Pages 383-394
Blood Pressure Variability
Pages 395-417
Home Blood Pressure Monitoring in Prehypertension and Hypertension
Pages 419-435
Morning Surge of Blood Pressure in Prehypertension and Hypertension
Pages 437-449
Physical Activity and Exercise Training as Important Modifiers of Vascular Health
Pages 451-469
Role of Ambulatory Blood Pressure Monitoring in Prehypertension
Pages 471-491
Sympathoadrenal Reactivity to Stress as a Predictor of Cardiovascular Risk Factors
Pages 493-525
Early Cardiovascular Dysfunction in Prehypertension
Pages 529-549
Neurogenic Mechanisms in Prehypertension and Pharmacologic Approaches to the Prevention and Treatment of Hypertension: Highlights of Professor Stevo Julius’ Scientific Contributions
Pages 553-569
The PREVER Study
Pages 571-582
Antihypertensive Drugs and Vascular Health
Pages 585-605
Management of Prehypertension and Hypertension in Women of Childbearing Age
Pages 607-627
Non-pharmacologic Approaches for the Management of Prehypertension
Pages 629-642
Prehypertension: A Case in Favor of Early Use of Diuretics
Pages 643-656
Prehypertension in the Era of Personalized Medicine in 2017
Pages 657-675
Treatment of High-Normal Blood Pressure in the Guidelines
Pages 677-689
Sei sicuro di voler eseguire questa azione?